Abbott Laboratories (LON:0Q15)

London flag London · Delayed Price · Currency is GBP · Price in USD
131.36
-0.71 (-0.53%)
At close: Aug 27, 2025
-0.53%
Market Cap169.24B
Revenue (ttm)31.47B
Net Income (ttm)10.17B
Shares Outn/a
EPS (ttm)5.82
PE Ratio16.65
Forward PE24.12
Dividend1.79 (1.36%)
Ex-Dividend DateJul 15, 2025
Volume22,889
Average Volume6,880
Open131.91
Previous Close132.06
Day's Range130.65 - 131.91
52-Week Range105.68 - 141.41
Beta0.66
RSI48.59
Earnings DateOct 15, 2025

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism,... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 1888
Employees 114,000
Stock Exchange London Stock Exchange
Ticker Symbol 0Q15
Full Company Profile

Financial Performance

In 2024, Abbott Laboratories's revenue was $41.95 billion, an increase of 4.59% compared to the previous year's $40.11 billion. Earnings were $13.35 billion, an increase of 134.19%.

Financial numbers in USD Financial Statements

News

There is no news available yet.